查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1379124

2023-2028年依產品、應用（低丙種球蛋白血症、慢性發炎性脫髓鞘多發性神經病變、免疫缺陷症、重症肌無力等）、分娩方式及地區分類的免疫球蛋白市場報告

Immunoglobulin Market Report by Product, Application (Hypogammaglobulinemia, Chronic Inflammatory Demyelinating Polyneuropathy, Immunodeficiency Disease, Myasthenia Gravis, and Others), Mode of Delivery, and Region 2023-2028
出版日期: | 出版商: IMARC | 英文 144 Pages | 商品交期: 2-3個工作天內

價格

概要

2022年全球免疫球蛋白市場規模達147億美元。展望未來， IMARC Group預計到2028年市場規模將達到211億美元，2022-2028年複合年成長率（CAGR）為6.2%。

免疫球蛋白也稱為抗體，是指由血漿或白血球 (WBC) 產生的一類糖蛋白分子。它們通常存在於免疫系統的血清和細胞中，並透過明確識別和結合抗原（例如細菌或病毒）而發揮抗體的作用，並幫助破壞它們。他們的檢驗幫助醫生診斷免疫缺陷、過敏和自體免疫疾病，如幼年特發性關節炎、紅斑性狼瘡和乳糜瀉。目前，世界各地有不同類別的免疫球蛋白，取決於生物學特徵、結構、標靶特異性和分佈。

免疫球蛋白市場趨勢：

由於快速的城市化和繁忙的日程安排，個人速食消費量有所增加。再加上久坐的生活方式以及患有多發性骨髓瘤、華氏巨球蛋白血症和自體免疫疾病等疾病的患者數量不斷增加，是推動市場成長的主要因素之一。此外，人們對早期診斷的認知不斷提高以及對個人化藥物的日益偏好也促進了市場的成長。而且，免疫球蛋白透過多種給藥途徑幫助人體對抗各種傳染病。因此，隨著冠狀病毒病（COVID-19）住院患者數量的不斷增加以及迫切需要有效的治療方法來防止大流行的傳播，超免疫球蛋白被用作控制感染的有效藥物。除此之外，一些製藥公司正在推出新型和先進的免疫球蛋白，以提高治療神經系統疾病的效率。其他因素，例如增加研發 (R&D) 專案資金和改善醫療基礎設施等，預計將在未來幾年進一步推動市場成長。

本報告回答的關鍵問題

  • 2022年全球免疫球蛋白市場規模有多大？
  • 2023-2028年全球免疫球蛋白市場的預期成長率是多少？
  • 推動全球免疫球蛋白市場的關鍵因素是什麼？
  • COVID-19 對全球免疫球蛋白市場有何影響？
  • 根據應用，全球免疫球蛋白市場的細分如何？
  • 根據交付方式，全球免疫球蛋白市場的詳細情形如何？
  • 全球免疫球蛋白市場的關鍵區域有哪些？
  • 誰是全球免疫球蛋白市場的主要參與者/公司？

目錄

第 1 章：前言

第 2 章：範圍與方法

  • 研究目的
  • 利害關係人
  • 資料來源
    • 主要資源
    • 二手資料
  • 市場預測
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第 3 章：執行摘要

第 4 章：簡介

  • 概述
  • 主要行業趨勢

第 5 章：全球免疫球蛋白市場

  • 市場概況
  • 市場業績
  • COVID-19 的影響
  • 市場預測

第 6 章：按產品分類的市場區隔

  • 免疫球蛋白G
    • 市場走向
    • 市場預測
  • 免疫球蛋白A
    • 市場走向
    • 市場預測
  • 免疫球蛋白M
    • 市場走向
    • 市場預測
  • 免疫球蛋白E
    • 市場走向
    • 市場預測
  • 免疫球蛋白D
    • 市場走向
    • 市場預測

第 7 章：按應用分類的市場區隔

  • 低丙種球蛋白血症
    • 市場走向
    • 市場預測
  • 慢性發炎性脫髓鞘多發性神經病變 (CIDP)
    • 市場走向
    • 市場預測
  • 免疫缺陷症
    • 市場走向
    • 市場預測
  • 重症肌無力
    • 市場走向
    • 市場預測
  • 其他
    • 市場走向
    • 市場預測

第 8 章：以交付方式分類的市場

  • 靜脈給藥方式
    • 市場走向
    • 市場預測
  • 皮下給藥方式
    • 市場走向
    • 市場預測

第 9 章：按地區分類的市場區隔

  • 北美洲
    • 美國
      • 市場走向
      • 市場預測
    • 加拿大
      • 市場走向
      • 市場預測
  • 亞太
    • 中國
      • 市場走向
      • 市場預測
    • 日本
      • 市場走向
      • 市場預測
    • 印度
      • 市場走向
      • 市場預測
    • 韓國
      • 市場走向
      • 市場預測
    • 澳洲
      • 市場走向
      • 市場預測
    • 印尼
      • 市場走向
      • 市場預測
    • 其他
      • 市場走向
      • 市場預測
  • 歐洲
    • 德國
      • 市場走向
      • 市場預測
    • 法國
      • 市場走向
      • 市場預測
    • 英國
      • 市場走向
      • 市場預測
    • 義大利
      • 市場走向
      • 市場預測
    • 西班牙
      • 市場走向
      • 市場預測
    • 俄羅斯
      • 市場走向
      • 市場預測
    • 其他
      • 市場走向
      • 市場預測
  • 拉丁美洲
    • 巴西
      • 市場走向
      • 市場預測
    • 墨西哥
      • 市場走向
      • 市場預測
    • 其他
      • 市場走向
      • 市場預測
  • 中東和非洲
    • 市場走向
    • 按國家/地區分類的市場細分
    • 市場預測

第 10 章：SWOT 分析

  • 概述
  • 優勢
  • 弱點
  • 機會
  • 威脅

第 11 章：價值鏈分析

第 12 章：波特五力分析

  • 概述
  • 買家的議價能力
  • 供應商的議價能力
  • 競爭程度
  • 新進入者的威脅
  • 替代品的威脅

第 13 章：價格分析

第14章：競爭格局

  • 市場結構
  • 關鍵參與者
  • 關鍵參與者簡介
    • ADMA Biologics Inc.
    • Baxter international Inc.
    • Biotest AG
    • CSL Limited
    • Grifols SA
    • Kedrion SpA
    • LFB SA
    • Octapharma AG
    • Sanquin Plasma Products BV
    • Takeda Pharmaceutical Company Limited
Product Code: SR112023A4505

Abstract

The global immunoglobulin market size reached US$ 14.7 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 21.1 Billion by 2028, exhibiting a growth rate (CAGR) of 6.2% during 2022-2028.

Also known as antibodies, immunoglobulins refer to a class of glycoprotein molecules produced by plasma or white blood cells (WBCs). They are generally present in the serum and cells of the immune system and function as antibodies by explicitly recognizing and binding antigens, such as bacteria or viruses, and aiding in their destruction. Their tests help doctors diagnose immunodeficiencies, allergies, and autoimmune conditions like juvenile idiopathic arthritis, lupus, and celiac disease. At present, different classes of immunoglobulins are available around the world depending on biological features, structure, target specificity, and distribution.

Immunoglobulin Market Trends:

Due to rapid urbanization and hectic schedules, there is a rise in the consumption of fast food among individuals. This, along with sedentary lifestyles and the increasing number of patients with medical conditions like multiple myeloma, Waldenstrom macroglobulinemia, and autoimmune disorders, represents one of the primary factors impelling the growth of the market. Additionally, rising awareness about early diagnosis and the increasing preferences for personalized medicines are contributing to market growth. Moreover, immunoglobulins through a variety of routes of administration help the body fight various infectious diseases. As a result, with the rising number of hospitalized patients with coronavirus disease (COVID-19) and an urgent need for effective therapies to prevent the spread of the pandemic, hyperimmune globulin is utilized as an effective medicine in managing the infection. Apart from this, several pharmaceutical companies are introducing new and advanced immunoglobulins with improved efficiency for the treatment of neurological disorders. Other factors, such as increasing funding for research and development (R&D) projects and the improving healthcare infrastructure are anticipated to propel the market growth further in the coming years.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global immunoglobulin market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on product, application and mode of delivery.

Breakup by Product:

IgG

IgA

IgM

IgE

IgD

Breakup by Application:

Hypogammaglobulinemia

Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

Immunodeficiency Disease

Myasthenia Gravis

Others

Breakup by Mode of Delivery:

Intravenous Mode of Delivery

Subcutaneous Mode of Delivery

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being ADMA Biologics Inc., Baxter international Inc., Biotest AG, CSL Limited, Grifols S.A, Kedrion S.p.A, LFB SA, Octapharma AG, Sanquin Plasma Products B.V. and Takeda Pharmaceutical Company Limited.

Key Questions Answered in This Report

  • 1. What was the size of the global immunoglobulin market in 2022?
  • 2. What is the expected growth rate of the global immunoglobulin market during 2023-2028?
  • 3. What are the key factors driving the global immunoglobulin market?
  • 4. What has been the impact of COVID-19 on the global immunoglobulin market?
  • 5. What is the breakup of the global immunoglobulin market based on the application?
  • 6. What is the breakup of the global immunoglobulin market based on the mode of delivery?
  • 7. What are the key regions in the global immunoglobulin market?
  • 8. Who are the key players/companies in the global immunoglobulin market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Immunoglobulin Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product

  • 6.1 IgG
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 IgA
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 IgM
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 IgE
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast
  • 6.5 IgD
    • 6.5.1 Market Trends
    • 6.5.2 Market Forecast

7 Market Breakup by Application

  • 7.1 Hypogammaglobulinemia
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Immunodeficiency Disease
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Myasthenia Gravis
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Others
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast

8 Market Breakup by Mode of Delivery

  • 8.1 Intravenous Mode of Delivery
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Subcutaneous Mode of Delivery
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 ADMA Biologics Inc.
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
    • 14.3.2 Baxter international Inc.
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
      • 14.3.2.3 Financials
      • 14.3.2.4 SWOT Analysis
    • 14.3.3 Biotest AG
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
      • 14.3.3.4 SWOT Analysis
    • 14.3.4 CSL Limited
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
      • 14.3.4.4 SWOT Analysis
    • 14.3.5 Grifols S.A
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 Financials
      • 14.3.5.4 SWOT Analysis
    • 14.3.6 Kedrion S.p.A
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
    • 14.3.7 LFB SA
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
    • 14.3.8 Octapharma AG
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 SWOT Analysis
    • 14.3.9 Sanquin Plasma Products B.V.
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
    • 14.3.10 Takeda Pharmaceutical Company Limited
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
      • 14.3.10.3 Financials
      • 14.3.10.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Immunoglobulin Market: Major Drivers and Challenges
  • Figure 2: Global: Immunoglobulin Market: Sales Value (in Billion US$), 2017-2022
  • Figure 3: Global: Immunoglobulin Market Forecast: Sales Value (in Billion US$), 2023-2028
  • Figure 4: Global: Immunoglobulin Market: Breakup by Product (in %), 2022
  • Figure 5: Global: Immunoglobulin Market: Breakup by Application (in %), 2022
  • Figure 6: Global: Immunoglobulin Market: Breakup by Mode of Delivery (in %), 2022
  • Figure 7: Global: Immunoglobulin Market: Breakup by Region (in %), 2022
  • Figure 8: Global: Immunoglobulin (IgG) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 9: Global: Immunoglobulin (IgG) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 10: Global: Immunoglobulin (IgA) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 11: Global: Immunoglobulin (IgA) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 12: Global: Immunoglobulin (IgM) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 13: Global: Immunoglobulin (IgM) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 14: Global: Immunoglobulin (IgE) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 15: Global: Immunoglobulin (IgE) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 16: Global: Immunoglobulin (IgD) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 17: Global: Immunoglobulin (IgD) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 18: Global: Immunoglobulin (Hypogammaglobulinemia) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 19: Global: Immunoglobulin (Hypogammaglobulinemia) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 20: Global: Immunoglobulin (Chronic Inflammatory Demyelinating Polyneuropathy-CIDP) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 21: Global: Immunoglobulin (Chronic Inflammatory Demyelinating Polyneuropathy-CIDP) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 22: Global: Immunoglobulin (Immunodeficiency Disease) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 23: Global: Immunoglobulin (Immunodeficiency Disease) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 24: Global: Immunoglobulin (Myasthenia Gravis) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 25: Global: Immunoglobulin (Myasthenia Gravis) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 26: Global: Immunoglobulin (Other Applications) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 27: Global: Immunoglobulin (Other Applications) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 28: Global: Immunoglobulin (Intravenous Mode of Delivery) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 29: Global: Immunoglobulin (Intravenous Mode of Delivery) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 30: Global: Immunoglobulin (Subcutaneous Mode of Delivery) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 31: Global: Immunoglobulin (Subcutaneous Mode of Delivery) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 32: North America: Immunoglobulin Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 33: North America: Immunoglobulin Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 34: United States: Immunoglobulin Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 35: United States: Immunoglobulin Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 36: Canada: Immunoglobulin Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 37: Canada: Immunoglobulin Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 38: Asia-Pacific: Immunoglobulin Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 39: Asia-Pacific: Immunoglobulin Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 40: China: Immunoglobulin Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 41: China: Immunoglobulin Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 42: Japan: Immunoglobulin Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 43: Japan: Immunoglobulin Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 44: India: Immunoglobulin Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 45: India: Immunoglobulin Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 46: South Korea: Immunoglobulin Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 47: South Korea: Immunoglobulin Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 48: Australia: Immunoglobulin Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 49: Australia: Immunoglobulin Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 50: Indonesia: Immunoglobulin Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 51: Indonesia: Immunoglobulin Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 52: Others: Immunoglobulin Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 53: Others: Immunoglobulin Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 54: Europe: Immunoglobulin Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 55: Europe: Immunoglobulin Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 56: Germany: Immunoglobulin Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 57: Germany: Immunoglobulin Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 58: France: Immunoglobulin Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 59: France: Immunoglobulin Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 60: United Kingdom: Immunoglobulin Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 61: United Kingdom: Immunoglobulin Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 62: Italy: Immunoglobulin Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 63: Italy: Immunoglobulin Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 64: Spain: Immunoglobulin Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 65: Spain: Immunoglobulin Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 66: Russia: Immunoglobulin Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 67: Russia: Immunoglobulin Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 68: Others: Immunoglobulin Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 69: Others: Immunoglobulin Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 70: Latin America: Immunoglobulin Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 71: Latin America: Immunoglobulin Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 72: Brazil: Immunoglobulin Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 73: Brazil: Immunoglobulin Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 74: Mexico: Immunoglobulin Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 75: Mexico: Immunoglobulin Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 76: Others: Immunoglobulin Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 77: Others: Immunoglobulin Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 78: Middle East and Africa: Immunoglobulin Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 79: Middle East and Africa: Immunoglobulin Market: Breakup by Country (in %), 2022
  • Figure 80: Middle East and Africa: Immunoglobulin Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 81: Global: Immunoglobulin Industry: SWOT Analysis
  • Figure 82: Global: Immunoglobulin Industry: Value Chain Analysis
  • Figure 83: Global: Immunoglobulin Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Immunoglobulin Market: Key Industry Highlights, 2022 and 2028
  • Table 2: Global: Immunoglobulin Market Forecast: Breakup by Product (in Million US$), 2023-2028
  • Table 3: Global: Immunoglobulin Market Forecast: Breakup by Application (in Million US$), 2023-2028
  • Table 4: Global: Immunoglobulin Market Forecast: Breakup by Mode of Delivery (in Million US$), 2023-2028
  • Table 5: Global: Immunoglobulin Market Forecast: Breakup by Region (in Million US$), 2023-2028
  • Table 6: Global: Immunoglobulin Market: Competitive Structure
  • Table 7: Global: Immunoglobulin Market: Key Players